Mar. 17 at 5:15 PM
$ABSI @JennyRowes - This is the classic cycle of biotechs....4-5 years after their IPO in the
$15 - $ 50 range trickling down 80-99%, the investment bankers and VC start coming out with the next wave of wealth transfer vehicles. How to rationalize why Generation Biomedicines can print
$400M out of the sky while ABSC, seemingly further along in the clinic only has a small fraction of that amount of cash remaining? Its the next new and shiny 'tech' with some buzzwords.
I did post a graph of this trend on Twits a couple years ago...
